PUBLISHER: IMARC | PRODUCT CODE: 1390619
PUBLISHER: IMARC | PRODUCT CODE: 1390619
The global radiotherapy market size reached US$ 6.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.5 Billion by 2028, exhibiting a growth rate (CAGR) of 4.57% during 2022-2028.
Radiotherapy, also known as radiation therapy, is used to slow down the growth of cancer cells and shrink tumors. It destroys the genetic material of cancer cells using high-energy particles or waves, such as x-rays, gamma rays, electron beams, or protons. It can be combined with other cancer treatments, such as surgery, chemotherapy, and immunotherapy, to improve their effectiveness. At present, it is offered to patients depending on their cancer type, size and location of the tumor, medical history, and age and medical conditions.
The rising prevalence of cancer on account of unhealthy dietary patterns, lack of physical activities, growing air pollution, and the increasing number of alcohol and tobacco consumption represents one of the key factors strengthening the growth of the market. Moreover, the risk of developing cancer rises dramatically with age as the tendency for cellular repair is less effective in older individuals. As a result, the rising geriatric population across the globe is acting as another significant growth-inducing factor. Apart from this, the development of effective, low-cost, and easy-to-use radiotherapy products is bolstering the growth of the market growth. In addition, modern radiotherapy techniques, such as three-dimensional (3D) conformal, intensity-modulated, and image-guided, deliver a lower dose of radiation to healthy tissues while a higher dose to the tumor. They also improve organ-at-risk (OAR) sparing and provide no physical sensation to patients. This is increasing their adoption in multiple applications and settings in chronic disease treatment, which, in turn, is catalyzing the demand for radiotherapy around the world. Furthermore, the market is projected to experience growth on account of the rising healthcare expenditure in both emerging and developed economies.
IMARC Group provides an analysis of the key trends in each sub-segment of the global radiotherapy market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, application and end user.
External Beam Radiation Therapy
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
Tomotherapy
Stereotactic Radiosurgery
Stereotactic Body Radiation Therapy
Proton Therapy
3D Conformal Radiotherapy (3D CRT)
Volumetric Modulated Arc Therapy (VMAT)
Internal Radiation Therapy/Brachytherapy
Systemic Radiation Therapy
Skin and Lip Cancer
Head and Neck Cancer
Breast Cancer
Prostate Cancer
Cervical Cancer
Lung Cancer
Others
Hospitals
Cancer Research Institutes
Ambulatory and Radiotherapy Centers
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Accuray Incorporated, Becton Dickinson and Company, Eckert & Ziegler, Elekta AB (publ), General Electric Company, Hitachi Ltd, Ion Beam Applications, Isoray Inc., Mevion Medical Systems Inc., Nordion Inc. (Sotera Health) and Siemens Healthineers AG (Siemens AG).